CERE
T. Rowe Price Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,824,387
| Closed | -$39.8M | – | 640 |
|
|
2023
Q3 | $39.8M | Sell |
1,824,387
-35,400
| -2% | -$773K | 0.03% | 395 |
|
|
2023
Q2 | $59.1M | Sell |
1,859,787
-141,781
| -7% | -$4.51M | 0.04% | 351 |
|
|
2023
Q1 | $48.8M | Sell |
2,001,568
-4,500
| -0.2% | -$110K | 0.04% | 372 |
|
|
2022
Q4 | $63.3M | Buy |
2,006,068
+4,631
| +0.2% | +$146K | 0.05% | 325 |
|
|
2022
Q3 | $56.6M | Buy |
+2,001,437
| New | +$56.6M | 0.05% | 332 |
|